| P2093 | author name string | Christiane Reitz | |
| P2860 | cites work | Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments | Q59053832 |
| | Clathrin-mediated endocytic proteins are upregulated in the cortex of the Tg2576 mouse model of Alzheimer’s disease-like amyloid pathology | Q60717635 |
| | Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions | Q70478363 |
| | Sequencing pools of individuals — mining genome-wide polymorphism data without big funding | Q22121997 |
| | TREM2 Variants in Alzheimer's Disease | Q22250873 |
| | Variant of TREM2 Associated with the Risk of Alzheimer's Disease | Q22250874 |
| | Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease | Q22251067 |
| | SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1 | Q24293566 |
| | Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease | Q24312938 |
| | Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease | Q24316501 |
| | Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation | Q24541447 |
| | Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease | Q24612662 |
| | The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease | Q24656574 |
| | An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene | Q24671954 |
| | R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study | Q27345528 |
| | Rarity of the Alzheimer disease-protective APP A673T variant in the United States | Q27346292 |
| | Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions | Q27672294 |
| | Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families | Q27860677 |
| | Mechanisms and functions of Eph and ephrin signalling | Q28208291 |
| | Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease | Q28241772 |
| | Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium | Q28252389 |
| | Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease | Q28254930 |
| | Candidate gene for the chromosome 1 familial Alzheimer's disease locus | Q28295424 |
| | Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease | Q28504767 |
| | Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis | Q28587217 |
| | Genome-wide survey of large rare copy number variants in Alzheimer's disease among Caribbean hispanics | Q28732171 |
| | Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families | Q28732285 |
| | Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease | Q28943325 |
| | The future of genetic studies of complex human diseases | Q29547215 |
| | Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative Stress | Q46021433 |
| | Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis | Q46076651 |
| | Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study | Q47790444 |
| | Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol | Q47954277 |
| | Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study | Q48095601 |
| | Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol | Q48161830 |
| | PLD3 in non-familial Alzheimer's disease | Q48251025 |
| | Reduced phospholipase D activity in brain tissue samples from Alzheimer's disease patients | Q48317761 |
| | Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition | Q48601482 |
| | Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes. | Q48693990 |
| | Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia | Q48939108 |
| | TREM2, frontotemporal dementia-like disease, Nasu-Hakola disease, and Alzheimer dementia: a chicken and egg problem? | Q50920078 |
| | Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? | Q51034742 |
| | APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. | Q51982797 |
| | Risk of dementia in first-degree relatives of patients with Alzheimer's disease and related disorders. | Q52100115 |
| | CD2-associated protein directly interacts with the actin cytoskeleton. | Q52547282 |
| | Apolipoprotein E type 4 allele and Alzheimer's disease: effect on age at onset and relative risk in different age groups. | Q53213414 |
| | Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. | Q53224110 |
| | Non-familial Alzheimer's disease is mainly due to genetic factors. | Q53250524 |
| | TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease. | Q53336994 |
| | Absence of A673T variant in APP gene indicates an alternative protective mechanism contributing to longevity in Chinese individuals. | Q53344904 |
| | Genetic variation in BIN1 gene and Alzheimer's disease risk in Han Chinese individuals. | Q53349762 |
| | PLD3 gene variants and Alzheimer's disease. | Q53363173 |
| | PLD3 and sporadic Alzheimer's disease risk. | Q53475066 |
| | TREM2 and neurodegenerative disease | Q57417653 |
| | TREM2 and Neurodegenerative Disease | Q57418387 |
| | Clinical and pathological correlates of apolipoprotein E ?4 in Alzheimer's disease | Q57620860 |
| | Understanding mechanisms underlying human gene expression variation with RNA sequencing | Q29614412 |
| | Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease | Q29614881 |
| | Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits | Q30497694 |
| | Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans | Q30540165 |
| | Involvement of formyl-peptide-receptor-like-1 and phospholipase D in the internalization and signal transduction of amyloid beta 1-42 in glial cells | Q30968711 |
| | Investigation of an amyloid precursor protein protective mutation (A673T) in a North American case-control sample of late-onset Alzheimer's disease | Q33562226 |
| | Deep sequencing of the Nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer's disease | Q33833796 |
| | Evidence against a role for rare ADAM10 mutations in sporadic Alzheimer disease | Q33855928 |
| | TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis | Q33864853 |
| | Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model | Q33915820 |
| | Identification of a CD20-, FcepsilonRIbeta-, and HTm4-related gene family: sixteen new MS4A family members expressed in human and mouse | Q33950856 |
| | The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease | Q33986970 |
| | Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. | Q34023677 |
| | Structural organization of the human MS4A gene cluster on Chromosome 11q12. | Q34085880 |
| | Clusterin | Q34119745 |
| | Excitation at the synapse: Eph receptors team up with NMDA receptors | Q34132914 |
| | A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease | Q34159318 |
| | Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3 | Q34229659 |
| | Genetics of clusterin isoform expression and Alzheimer's disease risk | Q34233544 |
| | Linking disease associations with regulatory information in the human genome | Q34298038 |
| | Coding variants in TREM2 increase risk for Alzheimer's disease | Q34307280 |
| | Siglec-mediated regulation of immune cell function in disease. | Q34314957 |
| | Genome-wide analysis of genetic loci associated with Alzheimer disease | Q34339530 |
| | Homozygous TREM2 mutation in a family with atypical frontotemporal dementia | Q34398459 |
| | Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease | Q34468561 |
| | Apolipoprotein E: From lipid transport to neurobiology | Q34497951 |
| | Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains | Q34506196 |
| | The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances | Q34574731 |
| | Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans | Q34617467 |
| | C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-beta (Abeta) and acts in concert with Abeta to elicit neuronal and behavioral deficits in mice | Q34651878 |
| | Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease | Q34662682 |
| | The Alzheimer's associated 5' region of the SORL1 gene cis regulates SORL1 transcripts expression | Q35050752 |
| | Epidemiology of neurodegeneration | Q35062651 |
| | Coding mutations in SORL1 and Alzheimer disease | Q35199225 |
| | Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease | Q35484526 |
| | TREM2 is associated with increased risk for Alzheimer's disease in African Americans | Q35589301 |
| | Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites | Q35693893 |
| | More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk. | Q35733491 |
| | Phospholipase D in brain function and Alzheimer's disease. | Q35893701 |
| | Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity | Q35950210 |
| | Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice | Q35978742 |
| | Rare coding mutations identified by sequencing of Alzheimer disease genome-wide association studies loci | Q35987583 |
| | Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases | Q36083108 |
| | ATP-binding cassette transporter A7 (ABCA7) loss of function alters Alzheimer amyloid processing | Q36115792 |
| | Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort | Q36424866 |
| | Modifier genes and sickle cell anemia | Q36433484 |
| | Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease | Q36604545 |
| | Comprehensive search for Alzheimer disease susceptibility loci in the APOE region | Q36630671 |
| | Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease | Q36784564 |
| | Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease | Q36899824 |
| | TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease | Q36952445 |
| | Interpreting noncoding genetic variation in complex traits and human disease | Q36988784 |
| | Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta | Q36996975 |
| | Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease | Q37228684 |
| | Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity | Q37357625 |
| | Functional screening in Drosophila identifies Alzheimer's disease susceptibility genes and implicates Tau-mediated mechanisms | Q37508556 |
| | Investigation of triggering receptor expressed on myeloid cells 2 variant in the Wisconsin Registry for Alzheimer's Prevention | Q37652950 |
| | Missense variant in TREML2 protects against Alzheimer's disease | Q37653009 |
| | Uncovering the roles of rare variants in common disease through whole-genome sequencing | Q37755970 |
| | Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease | Q38122876 |
| | Cardiovascular disease contributes to Alzheimer's disease: evidence from large-scale genome-wide association studies | Q38483442 |
| | Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status | Q39641831 |
| | CD20 homo-oligomers physically associate with the B cell antigen receptor. Dissociation upon receptor engagement and recruitment of phosphoproteins and calmodulin-binding proteins | Q39982968 |
| | Characterization of the VPS10 domain of SorLA/LR11 as binding site for the neuropeptide HA. | Q40677192 |
| | Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein | Q41226800 |
| | Amyloid beta protein (25-35) stimulation of phospholipases A, C and D activities of LA-N-2 cells | Q41343381 |
| | Intracellular trafficking of presenilin 1 is regulated by beta-amyloid precursor protein and phospholipase D1 | Q41894440 |
| | Induction of cytosolic calcium flux by CD20 is dependent upon B Cell antigen receptor signaling. | Q42165272 |
| | Enhancement of phospholipase D activity by overexpression of amyloid precursor protein in P19 mouse embryonic carcinoma cells | Q42513149 |
| | PLD3 variants in population studies | Q42725567 |
| | Eph receptors and neural plasticity | Q43546196 |
| | Absence of A673T amyloid-β precursor protein variant in Alzheimer's disease and other neurological diseases. | Q44866761 |
| P433 | issue | 6 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| | susceptibility locus | Q62091149 |
| P304 | page(s) | 547-558 | |
| P577 | publication date | 2015-12-01 | |
| P1433 | published in | Future Neurology | Q15760623 |
| P1476 | title | Novel susceptibility loci for Alzheimer's disease | |
| P478 | volume | 10 | |